We are live on ! Find out more
LNAI

Lunai Bioworks

27 hedge funds and large institutions have $403K invested in Lunai Bioworks in 2026 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 4

100% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 3

23% more funds holding

Funds holding: 2227 (+5)

0.08% less ownership

Funds ownership: 0.59%0.51% (-0.08%)

59% less capital invested

Capital invested by funds: $982K → $403K (-$578K)

Holders
27
Holders Change
+5
Holders Change %
+22.73%
% of All Funds
0.33%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
10
Increased
6
Reduced
3
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Optiver Holding
26
Optiver Holding
Netherlands
$4
Millennium Management
27
Millennium Management
New York
-$147K -20,843 Closed
Citadel Advisors
28
Citadel Advisors
Florida
-$18.2K -2,579 Closed
Jane Street
29
Jane Street
New York
-$10.5K -1,488 Closed
Bank of America
30
Bank of America
North Carolina
-$226 -32 Closed
Royal Bank of Canada
31
Royal Bank of Canada
Ontario, Canada
+$174 +35 +583%

LNAI Hedge Fund Activity: Q1 2026 in Review

27 of the 8,134 institutional investors tracked by Wall St. Rank reported a position in Lunai Bioworks (LNAI) for Q1 2026, worth a combined $403K — down 59% from $982K a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new LNAI positions and 4 closed out — a net gain of 6 holders — while 6 added to existing stakes and 3 trimmed.

The largest buyer was Citigroup, opening a new position worth an estimated $62.1K. The largest seller was Millennium Management, exiting entirely with an estimated $147K sold.

  • 27 institutional investors held Lunai Bioworks (LNAI) as of Q1 2026, up from 22 in Q4 2025.
  • Funds reported $403K of Lunai Bioworks stock for Q1 2026, down 59% quarter-over-quarter.
  • 10 funds opened new Lunai Bioworks positions in Q1 2026 and 4 closed out, a net change of +6 holders.
  • The largest Lunai Bioworks buyer in Q1 2026 was Citigroup, an estimated $62.1K added.
  • The largest Lunai Bioworks seller in Q1 2026 was Millennium Management, an estimated $147K sold.

Based on aggregated 13F filings for Q1 2026.